Botanix Pharmaceuticals Ltd
ASX:BOT

Watchlist Manager
Botanix Pharmaceuticals Ltd Logo
Botanix Pharmaceuticals Ltd
ASX:BOT
Watchlist
Price: 0.395 AUD 3.95% Market Closed
Market Cap: 717.9m AUD
Have any thoughts about
Botanix Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

BOT Price Targets Summary
Botanix Pharmaceuticals Ltd

Wall Street analysts forecast BOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BOT is 0.663 AUD with a low forecast of 0.657 AUD and a high forecast of 0.683 AUD.

Lowest
Price Target
0.657 AUD
66% Upside
Average
Price Target
0.663 AUD
68% Upside
Highest
Price Target
0.683 AUD
73% Upside
Botanix Pharmaceuticals Ltd Competitors:
Price Targets
128940
Hanmi Pharm Co Ltd
58% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
28% Upside
4569
Kyorin Holdings Inc
33% Upside
AFT
AFT Pharmaceuticals Ltd
33% Upside
CLN
Celon Pharma SA
2% Downside

Revenue
Forecast

Revenue Estimate
Botanix Pharmaceuticals Ltd

The compound annual growth rate of Botanix Pharmaceuticals Ltd's revenue for the next 3 years is 578%.

N/A
Past Growth
578%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Botanix Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
29%
Average Beat

Net Income
Forecast

Net Income Estimate
Botanix Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BOT's stock price target?
Price Target
0.663 AUD

According to Wall Street analysts, the average 1-year price target for BOT is 0.663 AUD with a low forecast of 0.657 AUD and a high forecast of 0.683 AUD.

What is Botanix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
578%

The compound annual growth rate of Botanix Pharmaceuticals Ltd's revenue for the next 3 years is 578%.

Back to Top